Ractopamine belongs to a group of beta-agonist compounds. It is a forbidden food additive in most countries because of the many reported collective intoxication outbreaks in humans. Because the drug can be rapidly metabolized and eliminated from animal body, the objective of this study was to develop an efficient and sensitive liquid chromatography-tandem mass spectrometry (LC-MS-MS) analytical method for the detection of ractopamine with cutoff below 1 ng/mL to extend the detection window after withdrawal of the drug and at the same time to meet the requirements of zerotolerance policy set by most countries. After solid-phase cleanup of the non-hydrolyzed and hydrolyzed urine samples, the residues were dissolved in methanol and analyzed directly by LC-MS-MS. Two transitions were monitored and one ratio determined. Samples reported as positive were required to have the ratio of the transitions within 20% of that determined from known calibration standards. The monitoring of the qualifying transition and requirement for its presence within a specific ratio to the primary ion has the potential of limiting the sensitivity of the assay. The limits of detection and quantitation of the assay were 0.1 and 0.25 ng/mL, respectively. The intraday precisions at 0.25 and 35 ng/mL were 4.88% and 0.95%, respectively. Interday precisions were 5.64% and 0.9% at the same concentrations. The percentage recoveries at 0.25 and 0.5 ng/mL were 117.8% and 108.4%, respectively.
Introduction
Ractopamine hydrochloride, a β-adrenoceptor agonist, is a phenethanolamine salt approved in the U.S. for use as a feed additive. It is recommended for use in animal feed to improve feed efficiency, to increase weight gain, and to improve carcass leanness (1, 2) . Despite the proven beneficial effects on animal performance that ractopramine has, there are a number of well-documented cases where the illegal use of similar compounds has resulted in human food poisoning (3, 4) , so most countries have abandoned the use of ractopamine in animal feed.
The European Union (EU) has banned the import of ractopamine-treated meat. As a result, all meat exported to the EU must undergo primary screening by a rapid method such as immunoassay. All positive samples are then subjected to confirmation tests such as liquid chromatography-mass spectrometry (LC-MS) (5) . For detection sensitivity, the suggested cutoff concentration of ractopamine for confirmation in the EU is 1 ng/mL, but in China and other Asian countries, the governments require that ractopamine must not be present at all in food (zero tolerance); therefore, more sensitive methods are needed to detect ractopamine in animal urine, feed, and tissue extracts.
Analytical techniques designed for the unambiguous detection and identification of ractopamine have been reported. In most laboratories, enzyme-linked immunosorbent assay (ELISA) is commonly used as screening method, and highperformance liquid chromatography (HPLC), gas chromatography (GC)-MS, and/or LC-MS are used for confirmation testing. For example, the Food Safety and Inspection Service of the U.S. Department of Agriculture used an HPLC method to detect ractopamine in animal tissue (6) . In China, both ELISA and rapid strip kits are accepted as screening methods, and HPLC, GC-MS, and LC-MS are used as confirmation methods (7) (8) (9) . In most published methods, where HPLC and GC-MS were used in detection of ractopamine (10) (11) (12) , the detection limits were between 0.5 and 5 µg/kg. Because of its high boiling point and poor thermal stability, HPLC is being used more frequently, but its sensitivity and accuracy are inadequate for a zero-tolerance program. Although GC-MS is a more sensitive, a derivatization procedure is required before ractopamine analysis. In order to achieve a higher sensitivity and a simpler test process, some LC-tandem MS methods for ractopamine have been reported (5, (13) (14) (15) . These published methods have limited application because of a lack of sensitivity (13) or very tedious sample treatment required before analysis (15) .
A highly sensitive LC-MS-MS method for the determination of ractopamine in animal urine has been developed. The procedure can be used for routine monitoring of ractopamine to meet the requirements of zero-tolerance policy.
The quantitation limit for ractopamine is 0.1 ng/mL, the accuracy is above 95%, and inter-and intraday precision are less than 10%. The ractopamine was extracted from urine samples, and the extract injected directly without derivatization.
Materials and Methods

Reagents and chemicals
Ractopamine hydrochloride and isoxuprine hydrochloride (ACS grade) were purchased from Sigma-Aldrich (Milwaukee, WI). All solvents were HPLC grade or better, and all chemicals were ACS grade.
Equipment
Solid-phase extraction columns (Clin II, 691-0353) were obtained from SPEWare (San Pedro, CA). Microtiter plate washer and reader were obtained from Tecan (San Jose, CA). System-48 Cerex sample concentrator and System-48 Cerex pressure processors were obtained from SPEWare (San Pedro, CA).
Calibrators
For the chromatographic calibration standards, a working solution containing internal standard was prepared in methanol at a concentration of 1000 ng/mL. Ractopamine standards were prepared in methanol at three concentrations 10, 100, and 1000 ng/mL. All the working solutions were stored at -20°C when not in use. For each batch, six calibration standards were prepared in ractopamine-free urine. Ractopamine concentrations of 0.1, 0.5, 1, 10, 25, and 50 ng/mL in urine were prepared; isoxuprine was used as the internal standard at a concentration of 10 ng/mL.
Sample preparation for chromatographic analysis
An aliquot of negative urine (1 mL) was pipetted into a screw cap centrifuge tube, 0.1 M sodium phosphate buffer (pH 6.0, 1 mL) was added. Solid-phase mixed mode extraction columns (Clin II, 691-0353T) were placed into a positive pressure vacuum manifold. The columns were first conditioned with methanol (3 mL), deionized water (3 mL), and 0.1 M phosphate buffer (1 mL, pH 6.0). The urine specimens were then loaded onto the columns, and after flowing through, the columns were washed with deionized water (2 mL), 1 M acetic acid (2 mL), and methanol (4 mL). The columns were then allowed to dry under nitrogen pressure for about 5min at 30 psi. The ractopamine was eluted from the columns with freshly prepared methylene chloride/isopropyl alcohol/ ammonium hydroxide (78:20:2, v/v/v, 3 mL). The extracts were evaporated to dryness under nitrogen and reconstituted in methanol (50 µL). The extracts were then transferred to autosampler vials and capped.
LC-MS-MS
An Agilent Technologies 1200 series LC pump coupled to a 6410 triple-quadrupole MS operating in positive electrospray ionization mode (ESI) was used for analysis. The LC column was a Zorbax Eclipse XDB C18 (4.6 × 50 mm × 1.8 μm), the column temperature was held at 40°C, and the injection volume was 5 μL. The mobile phase consisted of solvent A: 20 mM ammonium formate (pH 6.4) and solvent B: methanol, and both the composition of the mobile phase (15% B) and the flow rate (0.7 mL/min), remained constant throughout the run. The post time necessary to allow the system to re-equilibrate was 3.5 min. The gas temperature was 350°C, the gas flow was 1 L/min, and the nebulizer pressure was 50 psi. Nitrogen was used as the collision gas, and the capillary voltage was 4000V. Figure 1 shows the scanned ions peak for ractopamine and isoxuprine. For ractopamine, as shown in Figure 1A , m/z 302.2-164.1 and m/z 302.2-121.2 were more intense and different from the internal standard transitions, so they were chosen for monitoring; isoxuprine ions were produced at m/z 302.1-284.2, as shown in Figure 1B . Two transitions were selected and optimized for each drug using flow injection analysis. Table I shows the optimized fragment voltages for the parent ion (M+1) and the collision energy for fragmentation of the product ions. Each subsequent analysis required the ratio between the quantitative ion and the qualifier ion to be within ± 20% in order to meet the criterion for a positive result.
Data analysis
The assay was calibrated using linear regression analysis over a concentration range of 0.1-50 ng/mL for ractopamine. Peak-area ratios of target analytes and their respective standards were calculated using Mass Hunter soft- ware (Agilent). The data were fit to a linear least-squares regression curve with a 1/x weighting and not forced through the origin.
Selectivity
Ractopamine-free samples were extracted and analyzed according to the described procedure in order to assess interference from extraction or matrix, or potential ion suppression. In addition, interferences from commonly encountered drugs were added to the drug-free urines and subjected to the same extraction and analysis procedures. The following animal drugs were analyzed using the described procedures at a concentration of 10,000 ng/mL: clenbuterol, cycloclenbuterol, terbutaline, teolterodine, ciprofloxacin, melamine, tulobuterol, ofloxacin, norfloxacin, and pefloxacin.
Linearity and sensitivity
The linearity of the assay was established with six calibration points, excluding the drug-free matrix. The sensitivity if the method was determined by establishing the limit of quantitation (LOQ) defined as the lowest concentration detectable with a signal-to-noise (S:N) ratio of at least 5 and retention time within 0.2 min of the calibration standard. Any specimens found to be beyond the linear range of the assay were diluted so as to be accurately quantitated within the linear portion of the curve.
Precision
Inter-and intraday assay precision of the assays was determined at the calibration points of 0.25 and 35 ng/mL. Intraday data were obtained from six analyses performed on 1 day; interday data were obtained by analyzing a total of 30 specimens over 5 days (6 samples per day for 5 days; n = 30).
Extract stability
The stability of ractopamine extracts at a concentration of 0.25 and 35 ng/mL was determined by allowing the autosampler vials to remain in the LC chamber for 48 h, after which time they were re-analyzed. The unit was maintained at 7°C. The concentrations after 24 and 48 h were compared to those achieved on the first day of analysis.
Recovery
Using the Chambers et al. template (16) , the percentage recovery of ractopamine from the urine was determined by first assessing the response of the extracted samples (n = 3) prepared in synthetic urine, at a concentration of 0.25 and 0.5 ng/mL {R ES }. Next, urine was extracted, and drug was added post-extraction at a concentration of 0.25 and 0.5 ng/mL (n = 3){R PES }. The percentage recovery was then calculated from the equation (R ES /R PES ) × 100.
Again, we determined the percentage reduction or improvement in response due to matrix effects (ion suppression or ion enhancement) by assessing the peak area response of a non-extracted neat drug standard (n = 3) at a concentration of 0.25 and 0.5 ng/mL {R NES }. The unextracted solution was analyzed in the same reconstitution solvent as the extracted specimens. The % matrix effect was then calculated using the equation [(R PES /R NES ) -1] × 100.
Application to urine samples of cow and sheep
As part of various on-going research studies, positive urine samples from cattle and sheep were obtained from Dr. Shelver (USDA-ARS, Biosciences Research Laboratory, Fargo, ND). The urines were collected from the first day to the seventh day during feeding and withdrawal periods. All samples were analyzed using GC-MS method as described by Charlie et al. (10) with a testing limit of 5 ng/mL, then re-analyzed by LC-MS-MS.
Results and Discussion
The chromatographic procedure developed for ractopamine was validated by determining accuracy, precision, and linearity, limit of quantitation, selectivity, and extract stability. The limit of quantitation was 0.25 ng/mL. The detection limit meets the recommended concentrations in China, which requires zero tolerance, and surpasses the recommended concentrations of EU (cutoff of 1 ng/mL in animal urine).
Linearity, sensitivity, and interference
The limit of quantitation and calibration data were determined as described. Linearity was obtained with an average correlation coefficient > 0.99 over the dynamic range from 0.1 to 50 ng/mL. The mean correlation (n = 5) was 0.9996 and the equation of the slope of the calibration curve was y = 0.0358x + 0.0055 (Figure 2 ). The quantitation was not affected by the presence of the other animal drugs.
Precision, accuracy, and extract stability
The accuracy and precision of the assay were determined as described, and the data are shown in Table II . The procedure was very reliable, with a variation of 0.57% at 35 ng/mL and a variation of 4.88% at 0.25 ng/mL. Interday (between day) and intraday (same day) precision of the assay was determined using replicate analysis. The interday precision was 0.95% at 35 ng/mL and 4.32% at 0.25 ng/mL; the intraday precision was 0.9% at 35 ng/mL and 5.64% at 0.25 ng/mL. The stability of the extracts was assessed, and the results are shown in Table III . The extracted specimens were stable for at least two days when kept in the instrument rack inside the autosampler, which was maintained at 7°C. There was less than 5% difference in the quantitation of the extracts after 48 h. 
Extraction recovery, ion suppression, and matrix effects
The percentage recovery of the ractopamine from urine matrix and the matrix effects were determined, and the results are shown in Table IV . The extraction itself was relatively efficient for ractopamine (over 90% at 0.25 and 0.5 ng/mL).
Urine samples
Positive urine samples taken from cattle and sheep had previously been analyzed with HPLC (17) before being used as reference material to validate the LC-MS-MS method. It has been reported that less than 10% of free ractopamine is present in urine specimens (4, 17) , so one set of urine samples (0.1 mL) were analyzed without hydrolysis to detect the free ractopamine, and another set of urine samples were hydrolyzed with β-glucuronidase at 65°C for 3 h before SPE to detect the total amount of ractopamine. The effect of β-glucuronidase on ractopamine stability was evaluated by comparing the results for hydrolyzed samples and non-hydrolyzed samples fortified at 1, 5, and 10 ng/mL. The results are shown in Table V . The concentrations of ractopamine after enzyme hydrolysis are almost same as that without hydrolysis, indicating that the enzyme hydrolysis step does not cause loss or instability of ractopamine.
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The results for cows and sheep are shown in Table VI . During feeding and withdrawal, the ractopamine metabolites appeared a much higher concentrations than parent drug. After withdrawal of the drug, the concentrations of both free ractopamine and its metabolites rapidly decreased. However, with a cutoff concentration set at 0.25 ng/mL, the detection window was able to be extended to five days for free ractopamine and more than seven days if the hydrolysis process is employed before extraction and analysis.
Conclusions
The determination of ractopamine in urine has been described using LC-MS-MS. The procedure was reproducible, robust, and precise. The assay included monitoring a qualifying transition and calculation of a ratio required to be within 20% of that of a known calibration standard in order for definitive identification to be made. Because of the rapid metabolization of ractopamine, a highly sensitive confirmation method should be used in those countries where no ractopamine is allowed for feed additive.
